Trials / Recruiting
RecruitingNCT07521345
A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and the Food Effect of HSK55879 Tablets in Healthy Subjects.
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 46 (estimated)
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This is a single-center, random, double blind, placebo control clinical study to evaluate the safety, tolerability pharmacokinetics and food effect of HSK55879 in healthy subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HSK55879 | Dose 1 to dose 5 |
| DRUG | Placebo | dose 1 to dose 5 |
Timeline
- Start date
- 2026-03-20
- Primary completion
- 2026-06-01
- Completion
- 2026-06-15
- First posted
- 2026-04-09
- Last updated
- 2026-04-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07521345. Inclusion in this directory is not an endorsement.